PEAK6’s Thermo Fisher Scientific TMO Stock Holding History

PEAK6’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.2M	Buy	32,900 +20,400	+163%	+$11.1M	0.04%	425
2025 Q4	$7.24M	Buy	12,500 +12,300	+6,150%	+$6.96M	0.01%	786
2025 Q3	$97K	Sell	200 -11,300	-98%	-$5.26M	﹤0.01%	2611
2025 Q2	$4.66M	Sell	11,500 -23,700	-67%	-$9.91M	0.01%	1004
2025 Q1	$17.5M	Buy	35,200 +2,900	+9%	+$1.57M	0.04%	377
2024 Q4	$16.8M	Buy	+32,300	New	+$17.8M	0.04%	379

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PEAK6's TMO Position: Q1 2026 in Review

PEAK6 sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 3,920 shares — an estimated $2.13M sold.

PEAK6 first reported a position in TMO in Q4 2024 and held it in 5 quarters. The position peaked at $2.39M in Q4 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

PEAK6 reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
PEAK6 sold 3,920 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.13M.
PEAK6 first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 5 quarters.
PEAK6's Thermo Fisher Scientific position peaked at $2.39M in Q4 2024.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.